Potential for SSRIs as monotherapy for comorbid psychiatric disorders

Robert M A Hirschfeld

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.

Original languageEnglish (US)
Pages (from-to)1047-1050
Number of pages4
JournalAmerican Journal of Managed Care
Volume2
Issue number8
StatePublished - 1996

Fingerprint

Anxiety Disorders
Psychiatry
anxiety
Depression
phobia
Panic Disorder
Obsessive-Compulsive Disorder
Serotonin Uptake Inhibitors
Costs and Cost Analysis
costs
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Potential for SSRIs as monotherapy for comorbid psychiatric disorders. / Hirschfeld, Robert M A.

In: American Journal of Managed Care, Vol. 2, No. 8, 1996, p. 1047-1050.

Research output: Contribution to journalArticle

Hirschfeld, Robert M A. / Potential for SSRIs as monotherapy for comorbid psychiatric disorders. In: American Journal of Managed Care. 1996 ; Vol. 2, No. 8. pp. 1047-1050.
@article{4e124c15ab974d0c8ab4d1384e1face4,
title = "Potential for SSRIs as monotherapy for comorbid psychiatric disorders",
abstract = "The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.",
author = "Hirschfeld, {Robert M A}",
year = "1996",
language = "English (US)",
volume = "2",
pages = "1047--1050",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "8",

}

TY - JOUR

T1 - Potential for SSRIs as monotherapy for comorbid psychiatric disorders

AU - Hirschfeld, Robert M A

PY - 1996

Y1 - 1996

N2 - The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.

AB - The majority of patients with depression also will suffer from a comorbid anxiety disorder that may include panic disorder, obsessive-compulsive disorder, social phobia, or generalized anxiety disorder. The selective-serotonin reuptake inhibitors present an alternative and useful monotherapy in patients with depression and comorbid anxiety disorders. This treatment is likely to be highly cost-effective as well.

UR - http://www.scopus.com/inward/record.url?scp=0006233239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0006233239&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 1047

EP - 1050

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 8

ER -